CHARLES RIVER LABORATORIES INTERNATIONAL, INC. - 8-K Filing
Charles River Laboratories to acquire Frontage Holdings Corporation’s bioanalysis and DMPK operations for approximately $470 million in cash. (Items: 7.01 Regulation FD Disclosure On November 9, 2026, Charles River Laboratories International, Inc, 9.01 Financial Statements and Exhibits (d) Exhibits)